Cargando…
Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague
Plague is an ancient disease that continues to be of concern to both the public health and biodefense research communities. Pneumonic plague is caused by hematogenous spread of Yersinia pestis bacteria from a ruptured bubo to the lungs or by directly inhaling aerosolized bacteria. The fatality rate...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204441/ https://www.ncbi.nlm.nih.gov/pubmed/37218899 http://dx.doi.org/10.3390/antib12020033 |
_version_ | 1785045834644062208 |
---|---|
author | Biryukov, Sergei S. Wu, Hua Dankmeyer, Jennifer L. Rill, Nathaniel O. Klimko, Christopher P. Egland, Kristi A. Shoe, Jennifer L. Hunter, Melissa Fetterer, David P. Qiu, Ju Davies, Michael L. Bausch, Christoph L. Sullivan, Eddie J. Luke, Thomas Cote, Christopher K. |
author_facet | Biryukov, Sergei S. Wu, Hua Dankmeyer, Jennifer L. Rill, Nathaniel O. Klimko, Christopher P. Egland, Kristi A. Shoe, Jennifer L. Hunter, Melissa Fetterer, David P. Qiu, Ju Davies, Michael L. Bausch, Christoph L. Sullivan, Eddie J. Luke, Thomas Cote, Christopher K. |
author_sort | Biryukov, Sergei S. |
collection | PubMed |
description | Plague is an ancient disease that continues to be of concern to both the public health and biodefense research communities. Pneumonic plague is caused by hematogenous spread of Yersinia pestis bacteria from a ruptured bubo to the lungs or by directly inhaling aerosolized bacteria. The fatality rate associated with pneumonic plague is significant unless effective antibiotic therapy is initiated soon after an early and accurate diagnosis is made. As with all bacterial pathogens, drug resistance is a primary concern when developing strategies to combat these Yersinia pestis infections in the future. While there has been significant progress in vaccine development, no FDA-approved vaccine strategy exists; thus, other medical countermeasures are needed. Antibody treatment has been shown to be effective in animal models of plague. We produced fully human polyclonal antibodies in transchromosomic bovines vaccinated with the recombinant F1-V plague vaccine. The resulting human antibodies opsonized Y. pestis bacteria in the presence of RAW264.7 cells and afforded significant protection to BALB/c mice after exposure to aerosolized Y. pestis. These data demonstrate the utility of this technology to produce large quantities of non-immunogenic anti-plague human antibodies to prevent or possibly treat pneumonic plague in human. |
format | Online Article Text |
id | pubmed-10204441 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102044412023-05-24 Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague Biryukov, Sergei S. Wu, Hua Dankmeyer, Jennifer L. Rill, Nathaniel O. Klimko, Christopher P. Egland, Kristi A. Shoe, Jennifer L. Hunter, Melissa Fetterer, David P. Qiu, Ju Davies, Michael L. Bausch, Christoph L. Sullivan, Eddie J. Luke, Thomas Cote, Christopher K. Antibodies (Basel) Article Plague is an ancient disease that continues to be of concern to both the public health and biodefense research communities. Pneumonic plague is caused by hematogenous spread of Yersinia pestis bacteria from a ruptured bubo to the lungs or by directly inhaling aerosolized bacteria. The fatality rate associated with pneumonic plague is significant unless effective antibiotic therapy is initiated soon after an early and accurate diagnosis is made. As with all bacterial pathogens, drug resistance is a primary concern when developing strategies to combat these Yersinia pestis infections in the future. While there has been significant progress in vaccine development, no FDA-approved vaccine strategy exists; thus, other medical countermeasures are needed. Antibody treatment has been shown to be effective in animal models of plague. We produced fully human polyclonal antibodies in transchromosomic bovines vaccinated with the recombinant F1-V plague vaccine. The resulting human antibodies opsonized Y. pestis bacteria in the presence of RAW264.7 cells and afforded significant protection to BALB/c mice after exposure to aerosolized Y. pestis. These data demonstrate the utility of this technology to produce large quantities of non-immunogenic anti-plague human antibodies to prevent or possibly treat pneumonic plague in human. MDPI 2023-05-08 /pmc/articles/PMC10204441/ /pubmed/37218899 http://dx.doi.org/10.3390/antib12020033 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Biryukov, Sergei S. Wu, Hua Dankmeyer, Jennifer L. Rill, Nathaniel O. Klimko, Christopher P. Egland, Kristi A. Shoe, Jennifer L. Hunter, Melissa Fetterer, David P. Qiu, Ju Davies, Michael L. Bausch, Christoph L. Sullivan, Eddie J. Luke, Thomas Cote, Christopher K. Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague |
title | Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague |
title_full | Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague |
title_fullStr | Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague |
title_full_unstemmed | Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague |
title_short | Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague |
title_sort | polyclonal antibodies derived from transchromosomic bovines vaccinated with the recombinant f1-v vaccine increase bacterial opsonization in vitro and protect mice from pneumonic plague |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204441/ https://www.ncbi.nlm.nih.gov/pubmed/37218899 http://dx.doi.org/10.3390/antib12020033 |
work_keys_str_mv | AT biryukovsergeis polyclonalantibodiesderivedfromtranschromosomicbovinesvaccinatedwiththerecombinantf1vvaccineincreasebacterialopsonizationinvitroandprotectmicefrompneumonicplague AT wuhua polyclonalantibodiesderivedfromtranschromosomicbovinesvaccinatedwiththerecombinantf1vvaccineincreasebacterialopsonizationinvitroandprotectmicefrompneumonicplague AT dankmeyerjenniferl polyclonalantibodiesderivedfromtranschromosomicbovinesvaccinatedwiththerecombinantf1vvaccineincreasebacterialopsonizationinvitroandprotectmicefrompneumonicplague AT rillnathanielo polyclonalantibodiesderivedfromtranschromosomicbovinesvaccinatedwiththerecombinantf1vvaccineincreasebacterialopsonizationinvitroandprotectmicefrompneumonicplague AT klimkochristopherp polyclonalantibodiesderivedfromtranschromosomicbovinesvaccinatedwiththerecombinantf1vvaccineincreasebacterialopsonizationinvitroandprotectmicefrompneumonicplague AT eglandkristia polyclonalantibodiesderivedfromtranschromosomicbovinesvaccinatedwiththerecombinantf1vvaccineincreasebacterialopsonizationinvitroandprotectmicefrompneumonicplague AT shoejenniferl polyclonalantibodiesderivedfromtranschromosomicbovinesvaccinatedwiththerecombinantf1vvaccineincreasebacterialopsonizationinvitroandprotectmicefrompneumonicplague AT huntermelissa polyclonalantibodiesderivedfromtranschromosomicbovinesvaccinatedwiththerecombinantf1vvaccineincreasebacterialopsonizationinvitroandprotectmicefrompneumonicplague AT fettererdavidp polyclonalantibodiesderivedfromtranschromosomicbovinesvaccinatedwiththerecombinantf1vvaccineincreasebacterialopsonizationinvitroandprotectmicefrompneumonicplague AT qiuju polyclonalantibodiesderivedfromtranschromosomicbovinesvaccinatedwiththerecombinantf1vvaccineincreasebacterialopsonizationinvitroandprotectmicefrompneumonicplague AT daviesmichaell polyclonalantibodiesderivedfromtranschromosomicbovinesvaccinatedwiththerecombinantf1vvaccineincreasebacterialopsonizationinvitroandprotectmicefrompneumonicplague AT bauschchristophl polyclonalantibodiesderivedfromtranschromosomicbovinesvaccinatedwiththerecombinantf1vvaccineincreasebacterialopsonizationinvitroandprotectmicefrompneumonicplague AT sullivaneddiej polyclonalantibodiesderivedfromtranschromosomicbovinesvaccinatedwiththerecombinantf1vvaccineincreasebacterialopsonizationinvitroandprotectmicefrompneumonicplague AT lukethomas polyclonalantibodiesderivedfromtranschromosomicbovinesvaccinatedwiththerecombinantf1vvaccineincreasebacterialopsonizationinvitroandprotectmicefrompneumonicplague AT cotechristopherk polyclonalantibodiesderivedfromtranschromosomicbovinesvaccinatedwiththerecombinantf1vvaccineincreasebacterialopsonizationinvitroandprotectmicefrompneumonicplague |